Search hospitals > Maryland > Baltimore

Johns Hopkins Bayview Medical Center

Claim this profile
Baltimore, Maryland 21224
Global Leader in Syndrome
Conducts research for Lung Cancer
Conducts research for Stroke
Conducts research for Obesity
Conducts research for Gastroparesis
238 reported clinical trials
25 medical researchers
Photo of Johns Hopkins Bayview Medical Center in BaltimorePhoto of Johns Hopkins Bayview Medical Center in BaltimorePhoto of Johns Hopkins Bayview Medical Center in Baltimore

Summary

Johns Hopkins Bayview Medical Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Syndrome, Lung Cancer, Stroke, Obesity, Gastroparesis and other specialties. Johns Hopkins Bayview Medical Center is involved with conducting 238 clinical trials across 360 conditions. There are 25 research doctors associated with this hospital, such as Patrick Forde, MD, Pankaj Pasricha, MD, Guillermo Barahona, MD, and Alyssa Parian, MD.

Area of expertise

1Syndrome
Global Leader
Johns Hopkins Bayview Medical Center has run 12 trials for Syndrome.
2Lung Cancer
Johns Hopkins Bayview Medical Center has run 10 trials for Lung Cancer. Some of their research focus areas include:
Stage I
BRAF positive
Stage IV

Top PIs

Clinical Trials running at Johns Hopkins Bayview Medical Center

Opioid Use Disorder
Traumatic Brain Injury
Stroke
Chronic Obstructive Pulmonary Disease
Esophageal Cancer
Cognitive Impairment
Obesity
Cancer
Frailty
Alzheimer's Disease
Image of trial facility.

Opioid vs Non-Opioid Pain Management

for Postoperative Pain

The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids. The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.
Recruiting1 award N/A3 criteria
Image of trial facility.

Extended Release Buprenorphine

for Opioid Use Disorder

This study is a multi-site open-label randomized comparative effectiveness trial of a 28-day formulation of extended-release buprenorphine (XR-BUP) versus treatment as usual (TAU) for hospitalized patients with a moderate or severe opioid use disorder (OUD) seen by an addiction consultation service (ACS) and agreeing to initiate a medication for OUD (MOUD). Participants will be randomly assigned to XR-BUP or TAU to be received within 72 hours of anticipated hospital discharge. Follow up will occur at approximately 34, 90, and 180 days following hospital discharge.
Recruiting1 award Phase 2 & 3
Image of trial facility.

Suvorexant

for Opioid Use Disorder

This is a 4-week, randomized-controlled trial of suvorexant vs placebo in persons with opioid use disorder who have recent fentanyl exposure. Participants will first undergo a 5-day residential phase wherein participants are stabilized on sublingual buprenorphine/naloxone, followed by a 3-week outpatient phase wherein participants are maintained on sublingual buprenorphine/naloxone and transitioned to extended-release buprenorphine).
Recruiting0 awards Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Johns Hopkins Bayview Medical Center?
Johns Hopkins Bayview Medical Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Syndrome, Lung Cancer, Stroke, Obesity, Gastroparesis and other specialties. Johns Hopkins Bayview Medical Center is involved with conducting 238 clinical trials across 360 conditions. There are 25 research doctors associated with this hospital, such as Patrick Forde, MD, Pankaj Pasricha, MD, Guillermo Barahona, MD, and Alyssa Parian, MD.